MPN-433: Outcomes of COVID-19 in Hematopoietic Stem Cell Transplant Recipients: A Single-Institution, Observational Study

CONTEXT: Hematopoietic stem cell transplant (HSCT) recipients are generally considered high risk for poor outcomes following COVID-19 infection. The CIBMTR observational report published by Sharma et al. found that recipients of allogeneic HSCT who contracted COVID-19 had poor overall survival with...

Descripción completa

Detalles Bibliográficos
Autores principales: Dwabe, Sami, Savitala-Damerla, Lakshmi, Ladha, Abdullah, Tam, Eric, Chaudhary, Preet, Yaghmour, George
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2021
Materias:
Myeloproliferative Neoplasms
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8404081/
http://dx.doi.org/10.1016/S2152-2650(21)01844-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8404081/
http://dx.doi.org/10.1016/S2152-2650(21)01844-9

Ejemplares similares